Lundbeck France

Last updated: 13.02.2014

Address: 37-45, Quai du Président Roosevelt, 92445 Issy-les-Moulineaux Cedex, Paris, France

Tel: +33 (0)1 79 41 29 00


Company description

Lundbeck is one of Denmark’s most research-intensive enterprises. We employ a total of 1,100 highly-trained specialists in our research and development units. Each year, Lundbeck ploughs back more than 20% of its revenue into research and development.

In France, Lundbeck has recently moved into new facilities and generates 225 million Euro in sales. Already active in clinical trials in over 110 hospital units, in 2008 Lundbeck acquired long-time supplier Elaiapharm in the south of France to support its overall operations and thus further increasing their presence in the ‘Hexagon’.

Products and services

Centeral Nervous System:
Cipralex/Lexapro (depression)
Ebixa (Alzheimer’s disease)
Azilect (Parkinson’s disease)
Xenazine (chorea associated with Huntington’s disease)
Serdolect (schizophrenia)
Circadin (sleep disorders)



We use cookies to ensure that we give you the best experience on our site. For more info click here